About Skylight Pharmaceuticals Private Limited
Data last updated:
Skylight Pharmaceuticals Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC280526. Its GSTIN is 27AAXCS0291H1ZU (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sharma Anil Amit and Falak Amit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Gala 105 Ist Floor Gurukrupa Building A4 H No 486/B Thane Road, Bhiwandi, Maharashtra, India – 421302.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.17 Cr, a growth of 71% compared to the previous year. For the same year it recorded a net profit of ₹2.27 Lakh (net margin 1%) and EBITDA of ₹7.99 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years and 71% over five years.
As per MCA filings, the company has open charges of ₹40.97 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website skylightpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressGala 105 Ist Floor Gurukrupa Building A4 H No 486/B Thane Road, Bhiwandi, Maharashtra, India – 421302
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Skylight Pharmaceuticals Private Limited
The main business activity of Skylight Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Skylight Pharmaceuticals Private Limited FY 2023 filings available
Skylight Pharmaceuticals Private Limited reported revenue of ₹2.17 Cr (up 71% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Skylight Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 71% over five years, including 71% growth in the latest year. EBITDA rose 123% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Skylight Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.99 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.27 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Skylight Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Skylight Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Skylight Pharmaceuticals Private Limited
Skylight Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mefro Pharmaceuticals Pvt Ltd | ₹2.17 Cr (FY 2025) | •••• | •••• | 1341.0% | •••• | Punjab, India |
| VMG Pharmaceuticals Private Limited | ₹2.17 Cr (FY 2025) | •••• | •••• | -64.0% | •••• | Gurugram, Haryana, India |
| Toro Pharmaceuticals Private Limited | ₹2.17 Cr (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Lancer Drugs and Pharmaceuticals India Private Limited | ₹2.17 Cr (FY 2016) | •••• | •••• | 44.0% | •••• | Kochi, Kerala, India |
| Proteon Pharmaceuticals India Private Limited | ₹2.17 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Thane, Maharashtra, India |
| Skylight Pharmaceuticals Private Limited this company | ₹2.17 Cr (FY 2023) | •••• | •••• | 71.0% | •••• | Bhiwandi, Maharashtra, India |
| Koester Pharmaceuticals Private Limited | ₹2.17 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Bara Chauraha, Uttar Pradesh, India |
| Hilfen Pharmaceuticals Private Limited | ₹2.16 Cr (FY 2024) | •••• | •••• | 38.0% | •••• | Navi Mumbai, Maharashtra, India |
| Be-Line Pharmaceuticals Private Limited | ₹2.16 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Thanjavur, Tamil Nadu, India |
| Sirius Pharmaceuticals Private Limited | ₹2.16 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | Mumbai, Maharashtra, India |
| Donewell Pharmaceuticals Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Rangia, Assam, India |
Peers are the five companies nearest above and the five nearest below Skylight Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Skylight Pharmaceuticals Private Limited
Skylight Pharmaceuticals Private Limited is audited by Z S KHAN & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Z S KHAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Skylight Pharmaceuticals Private Limited
Skylight Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharma Anil Amit Also directs: Winmax Logistics Private Limited | Director | 30 Sep 2024 | 2 Years 0 Months | Current |
| Falak Amit Sharma | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
Ownership and Shareholding of Skylight Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Skylight Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2019 | State Bank of India | ₹40.97 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Skylight Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Skylight Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Skylight Pharmaceuticals Private Limited
Skylight Pharmaceuticals Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Sharma Anil Amit was appointed as Director on 30 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Skylight Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Skylight Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Skylight Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Skylight Pharmaceuticals Private Limited
Skylight Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCS0291H1ZU | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Skylight Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skylight Pharmaceuticals Private Limited
Skylight Pharmaceuticals is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC280526.
Skylight Pharmaceuticals reported revenue of ₹2.17 Cr for FY 2023 (up 71% YoY).
Skylight Pharmaceuticals has 2 current directors:
- Sharma Anil Amit - Director
- Falak Amit Sharma - Director
Skylight Pharmaceuticals reported a net profit of ₹2.27 Lakh (net margin 1%) and EBITDA of ₹7.99 Lakh (EBITDA margin 3.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Skylight Pharmaceuticals is 81% over three years and 71% over five years. In the latest year (FY 2023) revenue rose 71%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Skylight Pharmaceuticals is 27AAXCS0291H1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Skylight Pharmaceuticals is U74999MH2016PTC280526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skylight Pharmaceuticals was incorporated on 02 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Skylight Pharmaceuticals by revenue are Mefro Pharmaceuticals Pvt Ltd, VMG Pharmaceuticals Private Limited, Toro Pharmaceuticals Private Limited, Lancer Drugs and Pharmaceuticals India Private Limited, Proteon Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Sharma Anil Amit was appointed as Director on 30 Sep 2024. Sharma Anil Amit ceased to be Director on 25 Dec 2022. Falak Amit Sharma was appointed as Director on 30 Sep 2022. Skylight Pharmaceuticals has 6 board changes on record in total.
Skylight Pharmaceuticals can be reached through the website skylightpharmaceuticals.com. Its registered office is in Bhiwandi, Maharashtra, India.